Immediate Impact
2 by Nobel laureates 9 from Science/Nature 61 standout
Citing Papers
Targeting signaling pathways in prostate cancer: mechanisms and clinical trials
2022 Standout
Prostate cancer
2021 Standout
Works of K. N. being referenced
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
2015
Improved survival outcomes in clinically relevant patient subgroups from COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel-based chemotherapy.
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K. N. | 211 | 207 | 281 | 21 | 503 | |
| Karin Welén | 247 | 175 | 220 | 20 | 481 | |
| Diana Bello | 256 | 134 | 251 | 12 | 573 | |
| Victoria Rimkunas | 218 | 268 | 266 | 26 | 537 | |
| Hsi Chin Wu | 203 | 129 | 214 | 22 | 496 | |
| Jason Kirk | 130 | 121 | 289 | 16 | 477 | |
| Valerie Odero‐Marah | 213 | 258 | 323 | 22 | 569 | |
| Anna Wurtz | 284 | 263 | 256 | 19 | 566 | |
| Guowen Lin | 213 | 125 | 202 | 20 | 440 | |
| Guanglin Wu | 296 | 135 | 255 | 19 | 546 | |
| Carolyn Evan | 373 | 181 | 138 | 20 | 509 |
All Works
Loading papers...